DOCSLIB.ORG

Toxicological Profile for Nonylphenol

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Toxicological Profile for Nonylphenol TOXICOLOGICAL PROFILE FOR NONYLPHENOL September 2009 Integrated Risk Assessment Branch Office of Environmental Health Hazard Assessment California Environmental Protection Agency Toxicological Profile for Nonylphenol September 2009 Prepared by Office of Environmental Health Hazard Assessment Prepared for Ocean Protection Council Under an Interagency Agreement, Number 07-055, with the State Coastal Conservancy LIST OF CONTRIBUTORS Authors Jim Carlisle, D.V.M., Ph.D., Senior Toxicologist, Integrated Risk Assessment Branch David Chan, D.Env., Staff Toxicologist, Integrated Risk Assessment Branch Page Painter, M.D., Ph.D., Senior Toxicologist, Integrated Risk Assessment Branch Lily Wu, Ph.D., Associate Toxicologist, Reproductive and Cancer Hazard Assessment Branch Reviewers David Siegel, Ph.D., Chief, Integrated Risk Assessment Branch i Table of Contents Executive Summary ..................................................................................................................... iv Use and Exposure .................................................................................................................... iv Environmental Occurrence ...................................................................................................... iv Effects on Aquatic Life ........................................................................................................... iv Health Hazard and Toxicity in Humans and Laboratory Animals ........................................... v Abbreviations ............................................................................................................................. vii Introduction .................................................................................................................................. 1 Properties and Uses ...................................................................................................................... 1 Environmental Criteria and Contamination .................................................................................. 2 Environmental Fate, Transport, and Bio-uptake .......................................................................... 3 Toxicology: Marine and Other Aquatic Organisms .................................................................... 5 Reproductive and Developmental Toxicity .............................................................................. 5 Vitellogenin (VTG) Assay in Fish ....................................................................................... 5 Other Reproductive Endpoints in Fish ................................................................................. 6 Reproductive Effects on Invertebrates ................................................................................. 7 Other Types of Toxicity ........................................................................................................... 8 Other Toxicity in Fish .......................................................................................................... 8 Other Toxicity in Invertebrates ............................................................................................ 9 Summary and Aquatic Hazard Assessment .............................................................................. 9 Animal and Human Human Studies ............................................................................................. 9 Reproductive Toxicity .............................................................................................................. 9 Introduction .......................................................................................................................... 9 Laboratory Animal Studies ................................................................................................. 10 In Vitro Human Cell-Line Study ........................................................................................ 12 Summary ............................................................................................................................. 12 Developmental Toxicity ......................................................................................................... 12 Introduction ........................................................................................................................ 12 Laboratory Rodent Studies ................................................................................................. 13 Avian Studies ...................................................................................................................... 14 Human Studies .................................................................................................................... 14 Summary ............................................................................................................................. 14 Cancer ..................................................................................................................................... 14 Introduction ........................................................................................................................ 14 Laboratory Rodent Studies ................................................................................................. 15 Effects on Cultured Cells .................................................................................................... 15 Summary ............................................................................................................................. 15 Obesity .................................................................................................................................... 15 Introduction ........................................................................................................................ 15 Laboratory Studies .............................................................................................................. 15 Summary ............................................................................................................................. 16 Thyroid ................................................................................................................................... 16 Introduction ........................................................................................................................ 16 Laboratory Studies .............................................................................................................. 17 Summary ............................................................................................................................. 18 Immune System ...................................................................................................................... 18 ii Introduction ........................................................................................................................ 18 Laboratory Animal Studies ................................................................................................. 18 In Vitro Studies ................................................................................................................... 19 Summary ............................................................................................................................. 20 Nervous System ...................................................................................................................... 20 Introduction ........................................................................................................................ 20 In Vitro Studies ................................................................................................................... 20 Dopaminergic System ........................................................................................................ 21 Summary ............................................................................................................................. 22 Conclusions ................................................................................................................................ 23 Findings .................................................................................................................................. 23 Data Gaps ............................................................................................................................... 24 Recommendations .................................................................................................................. 24 References .................................................................................................................................. 25 Appendix 1: Effects of nonylphenol on aquatic organisms ....................................................... 37 iii Executive Summary This toxicological profile on nonylphenol (NP) describes its effects freshwater and marine life, humans, and laboratory animals. In recent years, NP and related chemical forms of NP have raised concerns because of their effects on the endocrine system, the organ system producing hormones that regulates many of the body's functions. Such concerns have led to many restrictions on the use of NPs within the European Union. Use and Exposure NP is a synthetic organic chemical produced in relatively large quantities in the United States. Primary uses include: (1) a building block of nonionic surfactants (i.e., agents that reduce surface tension of liquids) used in lubrication, defoaming agents, scouring fibers, emulsifiers, wetting
Load more

Recommended publications
  • Multi-Scale Impact of Chronic Exposure to Environmental Concentrations Of
    Multi-scale impact of chronic exposure to environmental concentrations of chlordecone in freshwater cnidarian, Hydra circumcincta Romain Colpaert, Pierre-Henri Villard, Laetitia de Jong, Marina Mambert, Karim Benbrahim, Joelle Abraldes, Claire Cerini, Valérie Pique, Maxime Robin, Xavier Moreau To cite this version: Romain Colpaert, Pierre-Henri Villard, Laetitia de Jong, Marina Mambert, Karim Benbrahim, et al.. Multi-scale impact of chronic exposure to environmental concentrations of chlordecone in freshwater cnidarian, Hydra circumcincta. Environmental Science and Pollution Research, Springer Verlag, 2020, 27 (33), pp.41052-41062. 10.1007/s11356-019-06859-4. hal-02451113 HAL Id: hal-02451113 https://hal-amu.archives-ouvertes.fr/hal-02451113 Submitted on 23 Jan 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Multi-scale impact of chronic exposure to environmental concentrations of chlordecone in freshwater cnidarian, Hydra circumcincta. Romain COLPAERT1, Pierre-Henri VILLARD1, Laetitia DE JONG1, Marina MAMBERT1, Karim BENBRAHIM1, Joelle ABRALDES1, Claire CERINI2, Valérie PIQUE1, Maxime ROBIN1, Xavier MOREAU1 1 : Aix Marseille Univ, Avignon Univ, CNRS, IRD, IMBE, Marseille, France 2 : Aix Marseille Univ, Inserm U1263, C2VN, Marseille, France Corresponding author: email : [email protected] phone : +33-(0)4-91-83-56-38 Abstract Chlordecone (CLD) is an organochlorine pesticide widely used by the past to control pest insects in banana plantations in the French West Indies.
    [Show full text]
  • Development and Validation of an HPLC-DAD Method for The
    separations Article Development and Validation of an HPLC-DAD Method for the Simultaneous Extraction and Quantification of Bisphenol-A, 4-Hydroxybenzoic Acid, 4-Hydroxyacetophenone and Hydroquinone in Bacterial Cultures of Lactococcus lactis Angelos T. Rigopoulos 1, Victoria F. Samanidou 2 ID and Maria Touraki 1,* ID 1 Laboratory of General Biology, Division of Genetics, Development and Molecular Biology, Department of Biology, School of Sciences, Aristotle University of Thessaloniki (A.U.TH.), 54 124 Thessaloniki, Greece; [email protected] 2 Laboratory of Analytical Chemistry, Department of Chemistry, School of Sciences, Aristotle University of Thessaloniki (A.U.TH.), 54 124 Thessaloniki, Greece; [email protected] * Correspondence: [email protected]; Tel.: +30-231-099-8292 Received: 8 January 2018; Accepted: 31 January 2018; Published: 6 February 2018 Abstract: Bisphenol-A, a synthetic organic compound with estrogen mimicking properties, may enter bloodstream through either dermal contact or ingestion. Probiotic bacterial uptake of bisphenol can play a major protective role against its adverse health effects. In this paper, a method for the quantification of BPA in bacterial cells of L. lactis and of BPA and its potential metabolites 4-hydroxybenzoic Acid, 4-hydroxyacetophenone and hydroquinone in the culture medium is described. Extraction of BPA from the cells was performed using methanol–H2O/TFA (0.08%) (5:1 v/v) followed by SPE. Culture medium was centrifuged and filtered through a 0.45 µm syringe filter. Analysis was conducted in a Nucleosil column, using a gradient of A (95:5 v/v H2O: ACN) and B (5:95 v/v H2O: ACN, containing TFA, pH 2), with a flow rate of 0.5 mL/min.
    [Show full text]
  • Is an Activator of the Human Estrogen Receptor Alpha
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Newcastle University E-Prints 1 The ionic liquid 1-octyl-3-methylimidazolium (M8OI) is an activator of the human estrogen receptor alpha Alistair C. Leitch1, Anne F. Lakey1, William E. Hotham1, Loranne Agius1, George E.N. Kass2, Peter G. Blain1, Matthew C. Wright1,* 1Institute Cellular Medicine, Health Protection Research Unit, Level 4 Leech, Newcastle University, Newcastle Upon Tyne, United Kingdom NE24HH. 2European Food Safety Authority, Via Carlo Magno 1A, 43126 Parma, Italy. *Corresponding author. Address: Institute Cellular Medicine, Level 4 Leech Building; Newcastle University, Framlington Place, Newcastle Upon Tyne, UK. [email protected] Email addresses: [email protected] (A. Leitch), [email protected] (A. Lakey), [email protected] (W. Hotham), [email protected] (L Aguis), , [email protected] (G Kass), [email protected] (P. Blain) [email protected] (M. Wright). Abbreviations AhR, aryl hydrocarbon receptor; ICI182780, also known as fulvestrant; E2, 17β estradiol; EE, ethinylestradiol; ERα, estrogen receptor alpha, also known as NR3A1; ERβ, estrogen receptor beta, also known as ER3A2; M8OI, 1-octyl-3-methylimidazolium chloride, also known as C8min; PBC, primary biliary cholangitis; PPARα, peroxisome proliferator activated receptor alpha; TFF1, trefoil factor 1. 2 ABSTRACT Recent environmental sampling around a landfill site in the UK demonstrated that unidentified xenoestrogens were present at higher levels than control sites; that these xenoestrogens were capable of super-activating (resisting ligand-dependent antagonism) the murine variant 2 ERβ and that the ionic liquid 1-octyl-3-methylimidazolium chloride (M8OI) was present in some samples.
    [Show full text]
  • Memorandum Date: June 6, 2014
    DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Memorandum Date: June 6, 2014 From: Bisphenol A (BPA) Joint Emerging Science Working Group Smita Baid Abraham, M.D. ∂, M. M. Cecilia Aguila, D.V.M. ⌂, Steven Anderson, Ph.D., M.P.P.€* , Jason Aungst, Ph.D.£*, John Bowyer, Ph.D. ∞, Ronald P Brown, M.S., D.A.B.T.¥, Karim A. Calis, Pharm.D., M.P.H. ∂, Luísa Camacho, Ph.D. ∞, Jamie Carpenter, Ph.D.¥, William H. Chong, M.D. ∂, Chrissy J Cochran, Ph.D.¥, Barry Delclos, Ph.D.∞, Daniel Doerge, Ph.D.∞, Dongyi (Tony) Du, M.D., Ph.D. ¥, Sherry Ferguson, Ph.D.∞, Jeffrey Fisher, Ph.D.∞, Suzanne Fitzpatrick, Ph.D. D.A.B.T. £, Qian Graves, Ph.D.£, Yan Gu, Ph.D.£, Ji Guo, Ph.D.¥, Deborah Hansen, Ph.D. ∞, Laura Hungerford, D.V.M., Ph.D.⌂, Nathan S Ivey, Ph.D. ¥, Abigail C Jacobs, Ph.D.∂, Elizabeth Katz, Ph.D. ¥, Hyon Kwon, Pharm.D. ∂, Ifthekar Mahmood, Ph.D. ∂, Leslie McKinney, Ph.D.∂, Robert Mitkus, Ph.D., D.A.B.T.€, Gregory Noonan, Ph.D. £, Allison O’Neill, M.A. ¥, Penelope Rice, Ph.D., D.A.B.T. £, Mary Shackelford, Ph.D. £, Evi Struble, Ph.D.€, Yelizaveta Torosyan, Ph.D. ¥, Beverly Wolpert, Ph.D.£, Hong Yang, Ph.D.€, Lisa B Yanoff, M.D.∂ *Co-Chair, € Center for Biologics Evaluation & Research, £ Center for Food Safety and Applied Nutrition, ∂ Center for Drug Evaluation and Research, ¥ Center for Devices and Radiological Health, ∞ National Center for Toxicological Research, ⌂ Center for Veterinary Medicine Subject: 2014 Updated Review of Literature and Data on Bisphenol A (CAS RN 80-05-7) To: FDA Chemical and Environmental Science Council (CESC) Office of the Commissioner Attn: Stephen M.
    [Show full text]
  • Toxicity Study of Bisphenol A, Nonylphenol, and Genistein in Rats
    linica f C l To o x l ic a o n r l o u g o Yamasaki and Ishii, J Clinic Toxicol 2012, 2:7 y J Journal of Clinical Toxicology DOI: 10.4172/2161-0495.1000e109 ISSN: 2161-0495 EditorialResearch Article OpenOpen Access Access Toxicity Study of Bisphenol A, Nonylphenol, and Genistein in Rats Neonatally Exposed to Low Doses Kanji Yamasaki*, and Satoko Ishii Chemicals Evaluation and Research Institute, 1-4-25 Kouraku, Bunkyo-ku, Tokyo 112-0004, Japan Due to reports that a considerable number of compounds may on PND 1 [10]. The investigators suggested that greater ER binding of have endocrine-disrupting activity in humans and animals, the estrogen occurs in the postnatal female reproductive tracts than in the Organization for Economic Co-operation and Development (OECD) prenatal reproductive tract and some placental barrier activity of BPA revised the original OECD Test Guideline No. 407 assay and introduced may be caused by the greater binding of estrogenic compounds to ERs in vivo screening tests in 2008 to detect endocrine-mediated effects. in the postnatal period. These suggestions demonstrate that neonatal These effects are one of the important parameters in assessing the exposure studies are useful means to detect the endocrine-mediated risk assessment of chemicals in the REACH program. Recently, risk effects of some estrogenic compounds. We therefore used the neonatal assessments of Bisphenol A (BPA) have conducted [1,2], and several exposure assay to test weakly estrogenic compounds. countries such as Canada, Denmark and France have adopted a The uterotrophic property of BPA, nonylphenol, and genistein was national ban on baby bottles made from polycarbonate plastic [3].
    [Show full text]
  • The Effect of Nonylphenol on Spermiogram, Hematological Properties and Reproductive Ability of Comet Goldfish ( Carassius Auratu
    The effect of nonylphenol on spermiogram, hematological properties and reproductive ability of comet goldfish (Carassius auratus) 1,2Muhamad Yamin, 3Eddy Supriyono, 3Kukuh Nirmala, 3Muhammad Zairin Jr., 3Enang Haris, 2Riani Rahmawati 1 Study Program of Aquaculture, Graduate School, Bogor Agricultural University, Bogor, Indonesia; 2 Research Institute for Ornamental Fish Culture (RIOFC), Indonesia; 3 Department of Aquaculture, Faculty of Fisheries and Marine Science, Bogor Agricultural University, Indonesia. Corresponding authors: M. Yamin, [email protected]; E. Supriyono, [email protected] Abstract. The degradation product of nonylphenoletoxilate (NPEO), nonylphenol (NP), had adverse effects on the reproduction of several species of male fish. In this study, spermatological properties of comet goldfish (Carrasius auratus) after a 30 day exposure with 0.03-0.30 mg NP L-1 were investigated. Mature C. auratus (weight: ~6.87 g; length: ~10.06 cm) were reared in 15 pairs of glass tank. Thirty days after exposure, significant dose-dependent effects of NP in the treated male fish groups were observed such as reduction in number of sperm, change in semen parameters, and suppressed reproductive behavior. High number of sperm was microscopically founded present in the semen control fish and fish treated by 0.03 mg NP/L, but was scarce in the 0.12 mg NP L-1 or higher concentration. Change of semen parameters (pH, color and sperm motility) were observed from fish treated by NP compared to control specimens. A breeding test of treated male fish paired with female matured normal fish revealed that NP suppressed reproductive behavior of male individuals. There were female normal fish spawned and egg hatched when paired with control male fish and treated by 0.03 mg NP L-1 but were remarkably no female fish spawned when paired with male fish treated by 0.12 mg NP L-1 or higher concentration.
    [Show full text]
  • Adverse Effects of Digoxin, As Xenoestrogen, on Some Hormonal and Biochemical Patterns of Male Albino Rats Eman G.E.Helal *, Mohamed M.M
    The Egyptian Journal of Hospital Medicine (October 2013) Vol. 53, Page 837– 845 Adverse Effects of Digoxin, as Xenoestrogen, on Some Hormonal and Biochemical Patterns of Male Albino Rats Eman G.E.Helal *, Mohamed M.M. Badawi **,Maha G. Soliman*, Hany Nady Yousef *** , Nadia A. Abdel-Kawi*, Nashwa M. G. Abozaid** Department of Zoology, Faculty of Science, Al-Azhar University (Girls)*, Department of Biochemistry, National organization for Drug Control and Research** Department of Biological and Geological Sciences, Faculty of Education, Ain Shams University*** Abstract Background: Xenoestrogens are widely used environmental chemicals that have recently been under scrutiny because of their possible role as endocrine disrupters. Among them is digoxin that is commonly used in the treatment of heart failure and atrial dysrhythmias. Digoxin is a cardiac glycoside derived from the foxglove plant, Digitalis lanata and suspected to act as estrogen in living organisms. Aim of the work: The purpose of the current study was to elucidate the sexual hormonal and biochemical patterns of male albino rats under the effect of digoxin treatment. Material and Methods: Forty six male albino rats (100-120g) were divided into three groups (16 rats for each). Half of the groups were treated daily for 15 days and the other half for 30 days. Control group: Animals without any treatment. Digoxin L group: orally received digoxin at low dose equivalent of 0.0045mg/200g.b.wt. Digoxin H group: administered digoxin orally at high dose equivalent of 0.0135mg/200g.b.wt. At the end of the experimental periods, blood was collected and serum was separated for estimation the levels of prolactin (PRL), FSH, LH, total testosterone (total T), aspartate amino transferase (AST), alanine amino transferase (ALT), alkaline phosphatase (ALP), urea, creatinine, total proteins, albumin, total lipids, total cholesterol (total-chol), Triglycerides (TG), low density lipoprotein cholesterol (LDL-chol) and high density lipoprotein cholesterol (HDL-chol).
    [Show full text]
  • Pdf/O401~001025.Pdf
    June 5,2007 Stephen Johnson, Administrator Environmental Protection Agency Ariel Rios Building 1200 Pennsylvania Avenue, NW Washington, D.C. 20460 Re: Citizen Petition to EPA Regarding Nonylphenol and Nonylphenol Ethoxylates Dear Administrator Johnson: Male fish produce female egg proteins when exposed to low levels of nonylphenol ("NP") and nonylphenol ethoxylate ("NPE") products.' Yet, the U.S. Environmental Protection Agency ("EPA") claims it is unable to set water quality criteria to prevent this unnatural result because it does not have compelling evidence that male fish making female egg proteins is bad for fish growth, reproduction or survival. EPA acknowledges the need for more re~earch.~ Fish may not be alone in responding in potentially dangerous ways to NP. Research published in the September 2006 edition of Toxicological Sciences shows that human placenta responds to NP in the first trime~ter.~The result may be early termination of pregnancy and fetal growth defect^.^ The potential for harm is salient. American manufacturers make more than 200 million pounds of NP each year, which is used to produce almost 400 million pounds of NPE products.5 Most of the NPE is used in a variety of residential and commercial cleaning products and is discharged to the 1 U.S. Environmental Protection Agency, Office of Water, Office of Science and Technology, Ambient Aquatic Life Water Quality Criteria Nonylphenol, December 2005, EPA-822-R-05-005.("EPA Criteria Document") www.epa.novlwatersciencelcriteria~aqlife.htm1Section 1.4 'Id.at page 7. 3 Bechi, N., Estrogen-Like Response to p-Nonylphenol in Human First Trimester Placenta and BeWo Choriocarcinorna Cells, Toxicological Sciences, 93(1), 75-8 1 (September, 2006).http:lltoxsci.oxford~ournals.org/cgi/content~full/93/1l75.
    [Show full text]
  • Reproductive Toxicity Study of Bisphenol A, Nonylphenol, and Genistein in Neonatally Exposed Rats
    J Toxicol Pathol 2005; 18: 203–207 Short Communication Reproductive Toxicity Study of Bisphenol A, Nonylphenol, and Genistein in Neonatally Exposed Rats Shuji Noda1, Takako Muroi1, Hideo Mitoma1, Saori Takakura1, Satoko Sakamoto1, Atsushi Minobe1, and Kanji Yamasaki1 1Chemicals Evaluation and Research Institute, 3–822, Ishii, Hita, Oita 877–0061, Japan Abstract: To investigate the endocrine-mediated effects of neonatal administration of the weak estrogenic compounds, bisphenol A, nonylphenol and genistein, were subcutaneously injected with these compounds at doses of 0.1, 1, and 10 µg/rat/day for 5 days starting on postnatal day 1. Rats were autopsied at 47–50 days. Positive control groups were given diethylstilbestrol (DES) at the same dose levels as the other chemicals. The ano-genital distance, age of vaginal opening and preputial separation, and estrus cyclicity for all living offspring were examined. No abnormalities by the injection of nonylphenol and genistein were detected in this study. In the BPA groups, ano-genital distance in the females in the 1 and 10 µg BPA groups was shorter than in the control group, and the ventral prostate weight was higher in the 10 µg BPA group than in the control group. On the other hand, in the DES groups, delayed preputial separation occurred later in the 0.1 and 1 µg groups than in the control group, and in the 10 µg groups, preputial separation was not completed. Also the estrous stage persisted in female of all DES groups. Underdevelopment of the seminal vesicle and prostate were observed in males of the 1 and 10 µg DES groups, and fewer ovarian corpus lutea, ovarian follicular cysts, and uterine glands, as well as increased uterine epithelial height and squamous metaplasia of the epithelium in the uterus were observed in females of all DES groups.
    [Show full text]
  • Estrogen Receptors in Polycystic Ovary Syndrome
    cells Review Estrogen Receptors in Polycystic Ovary Syndrome Xue-Ling Xu 1,†, Shou-Long Deng 2,3,†, Zheng-Xing Lian 1,* and Kun Yu 1,* 1 College of Animal Science and Technology, China Agricultural University, Beijing 100193, China; [email protected] 2 Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences, Ministry of Health, Beijing 100021, China; [email protected] 3 CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China * Correspondence: [email protected] (Z.-X.L.); [email protected] (K.Y.) † These authors contributed equally to this work. Abstract: Female infertility is mainly caused by ovulation disorders, which affect female reproduction and pregnancy worldwide, with polycystic ovary syndrome (PCOS) being the most prevalent of these. PCOS is a frequent endocrine disease that is associated with abnormal function of the female sex hormone estrogen and estrogen receptors (ERs). Estrogens mediate genomic effects through ERα and ERβ in target tissues. The G-protein-coupled estrogen receptor (GPER) has recently been described as mediating the non-genomic signaling of estrogen. Changes in estrogen receptor signaling pathways affect cellular activities, such as ovulation; cell cycle phase; and cell proliferation, migration, and invasion. Over the years, some selective estrogen receptor modulators (SERMs) have made substantial strides in clinical applications for subfertility with PCOS, such as tamoxifen and clomiphene, however the role of ER in PCOS still needs to be understood. This article focuses on the recent progress in PCOS caused by the abnormal expression of estrogen and ERs in the ovaries and uterus, and the clinical application of related targeted small-molecule drugs.
    [Show full text]
  • Structural and Mechanistic Insights Into Bisphenols Action Provide Guidelines for Risk Assessment and Discovery of Bisphenol a Substitutes
    Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes Vanessa Delfossea, Marina Grimaldib, Jean-Luc Ponsa, Abdelhay Boulahtoufb, Albane le Mairea, Vincent Cavaillesb, Gilles Labessea, William Bourgueta,1,2, and Patrick Balaguerb,1,2 aCentre de Biochimie Structurale, Institut National de la Santé et de la Recherche Médicale U1054, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5048, Universités Montpellier 1 and 2, 34090 Montpellier, France; and bInstitut de Recherche en Cancérologie de Montpellier, Institut National de la Santé et de la Recherche Médicale U896, Centre Régional de Lutte contre le Cancer Val d’Aurelle Paul Lamarque, Université Montpellier 1, 34298 Montpellier, France Edited* by Jan-Åke Gustafsson, Karolinska Institutet, Huddinge, Sweden, and approved August 2, 2012 (received for review March 1, 2012) Bisphenol A (BPA) is an industrial compound and a well known onset of obesity and other metabolic syndromes (9). In this regard, endocrine-disrupting chemical with estrogenic activity. The wide- a large body of data about endocrine-disrupting chemicals (EDCs) spread exposure of individuals to BPA is suspected to affect a variety underlines the importance of exposure during early stages of de- of physiological functions, including reproduction, development, and velopment, which could result in numerous biological defects in metabolism. Here we report that the mechanisms by which BPA and adult life (10). two congeners, bisphenol AF and bisphenol C (BPC), bind to and The molecular basis behind the deleterious effects of BPA is poorly understood, and a large controversy has been created activate estrogen receptors (ER) α and β differ from that used by 17β- within the field of endocrine disruption about low doses’ effects estradiol.
    [Show full text]
  • The Association Between Nonylphenols and Sexual Hormones Levels Among Pregnant Women: a Cohort Study in Taiwan
    The Association between Nonylphenols and Sexual Hormones Levels among Pregnant Women: A Cohort Study in Taiwan Chia-Huang Chang1,2, Ming-Song Tsai2,3, Ching-Ling Lin4, Jia-Woei Hou5, Tzu-Hao Wang6, Yen-An Tsai1, Kai-Wei Liao1, I-Fang Mao7, Mei-Lien Chen1* 1 Institute of Environmental and Occupational Health Sciences, School of Medicine, National Yang Ming University, Taipei, Taiwan, 2 Department of OBS & GYN, Cathay General Hospital, Taipei, Taiwan, 3 School of Medicine, Fu Jen Catholic University, Taipei, Taiwan, 4 Department of Endocrinology and Metabolism, Cathay General Hospital, Taipei, Taiwan, 5 Department of Pediatrics, Cathay General Hospital, Taipei, Taiwan, 6 Department of Obstetrics and Gynecology, College of Medicine, Chang Gung University Genomic Medicine Research Core Laboratory (GMRCL), Chang Gung Memorial Hospital, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 7 Department of Occupational Safety and Health, Chung Shan Medical University, Taichung, Taiwan Abstract Background: Nonylphenol (NP) has been proven as an endocrine disrupter and had the ability to interfere with the endocrine system. Though the health effects of NP on pregnant women and their fetuses are sustained, these negative associations related to the mechanisms of regulation for estrogen during pregnancy need to be further clarified. The objective of this study is to explore the association between maternal NP and hormonal levels, such as estradiol, testosterone, luteinizing hormone (LH) and follicle stimulating hormone (FSH), and progesterone. Methods: A pregnant women cohort was established in North Taiwan between March and December 2010. Maternal urine and blood samples from the first, second, and third trimesters of gestation were collected. Urinary NP concentration was measured by high-performance liquid chromatography coupled with fluorescent detection.
    [Show full text]